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Objective: Currently, diagnosis of IgA nephropathy (IgAN) relies on renal bi-
opsy. Most IgAN is progressive, however, renal biopsy cannot be done
frequently for its invasive property. This study is to investigate non-invasive
protein biomarkers of IgAN from urine supernatant.
Methods: Urine supernatant was collected from 15 IgAN patients (Lee’s
grade I-II, III and IV-V, 5 in each group), 12 none-IgAN glomerular disease con-
trol (DC) patients (MCD, MN and FSGS, 4 in each group) and 5 normal control
(NC). Urine sample were analyzed by Raybiotech protein array for searching
differential expression of protein biomarkers. Candidate protein biomarkers
were further validated in urine samples from other subjects, including 49
IgAN patients (Lee’s grade I-II 8, grade III 31 and grade IV-V 10), 28 DC pa-
tients (MCD 8, MN 8 and FSGS 12) and 14 NC by ELISA method.
Results: Angiostatinwas found differential expressed between IgAN group and
control groups by protein array. By ELISA verification, the level of angiostatin
was significantly higher in IgAN group than NC group (255.15 288.43 vs
3.31 5.96), but lower than DC group, including MN (579.47 211.69 ng/ml)
and MCD (664.56 375.95 ng/ml). Angiostatin showed a significant positive
correlation with SCr (rZ 0.939), BUN (rZ 0.931), Cys C (rZ 0.923), protein-
uria (r Z 0.784), global sclerosis (r Z 0.718) and crescentformation
(rZ 0.588). There was a negative correlation between angiostatin level and
eGFR (rZ0.721). Angiostatin level in IgAN Lee’s grade IV-V groupwas signif-
icantly higher than gradeI-II and grade III group (620.43 271.47 vs
107.38 83.37 vs 117.89 143.84 ng/ml, p < 0.01). The level of angiostatin
was significantly higher in IgAN group with endothelial cell proliferation
change than those without (406.95 336.56 vs 189.41 234.70, p < 0.01).
Conclusion: Urine supernatant angiostatin could be used as a candidate
biomarker for diagnosis of IgAN. Angiostatin level reflects the clinical and
pathological features of IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.093
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Objective: Most of IgA nephropathy (IgAN) is chronic progressive glomerulo-
nephritis, with different clinical and pathological features. Evaluation of the
disease by repeated renal biopsy is not practical due to its invasive proce-
dure. Urinary sediment miRNAs are hopeful to serve as non-invasive bio-
markers to assess kidney injury of IgAN.
Methods: 52 biopsy-proven IgAN patients and 25 healthy controls were
enrolled in this study. Urinary sediment miRNAs were extracted. Expressions
of miR-34a, miR-205, miR-21, miR-146a and miR-155 were quantified by
qPCR. ROC (receiver operating characteristic curve) was used to investigate
the value of the miRNAs for predicting dignosis of IgAN and evaluating histo-
pathological injury. The patients were treated according to the KDIGO guide-
line and followed up. The roles of miRNAs in reflecting theraputic efficacy
and disease progression were analyzed.
Results: (1) The IgAN group had significantly lower urinary miR-34a, miR-205,
miR-155 but higher miR-21 levels than controls. Logistic regression analysis
showed that urinary miR-34a0.047, miR-2050.209 and miR-210.461were independent factors for diagnosis of IgAN. The ROC revealed that miR-
2050.125 and miR-210.891 can distinguish IgAN patients with moderate
and severe tubular atrophy and interstitial fibrosis from those with mild
tubular atrophy and interstitial fibrosis. (2) After 21.17 months follow-up,
the level of proteinuria reduction (g/24h/month) was positively correlated
with baseline urinary miR-21 and inversely correlated with miR-205. The sub-
jectswho achieved a complete remission (CR) hadhigher baseline urinarymiR-
205, and lower miR-21 than those without achieveing a CR.
Conclusion: The levels of some urinary sediment miRNAs, especially baseline
miR-21 and miR-205 may be used as prognostic markers for evaluating the
tubulointerstitial damage of IgAN. What’s more, baseline levels of urinary miR-
NAs may be predictors to reflect theraputic efficacy and disease progression.http://dx.doi.org/10.1016/j.hkjn.2015.08.094
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Objective: Mesangial deposition of aberrantly glycosylated IgA1 (agIgA1) and its
immune complex is an initial and key pathogenicmechanism in IgA nephropathy
(IgAN). The present study tested the hypothesis that bacteria-derived IgA prote-
asesmaybeabletodegrade thecirculatinganddepositedagIgA1and its immune
complex locally in the mesangium and may represent a novel therapy for IgAN.
Methods:Wefirst identified bacterial IgA proteases with high enzymatic activ-
ity by screening 14 different bacterial strains (6 species totally). Among them,
4 IgA proteases were selected and their ability to degrade agIgA1 and its im-
mune complex was determined in vitro with artificially deglycosylated IgA1
or human IgAN biopsy and in vivo in a modified mouse model of passive IgAN.
Results: Selected bacteria-derived IgA proteases were capable of degrading
serum agIgA1 and normal IgA1 pretreated with neuraminidase and b-galacto-
sidase in vitro and also the deposited immune complex within the mesangium
of renal biopsy from IgAN patients. In a modified mouse model of passive IgAN
with abundant in situ mesangial deposition of the agIgA-IgG immune complex
in glomeruli, a single intravenous injection of bacterial IgA protease was able
to effectively degrade the deposited immune complex within the glomerulus.
Conclusion: The bacteria-derived IgA protease is a biologically active
enzyme that can specifically degrade serum agIgA systemically and the
deposited agIgA-IgG immune complex locally. Thus, the use of IgA protease
may represent a novel therapy for IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.095
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